NICE

The Association of the British Pharmaceutical Industry, in conjunction with the Office of Health Economics, invites you to register for a webinar on Monday 18th July: New EQ-5D-5L value sets for England and the UK and implications for HTA.

Work by Sarah Karlsberg Schaffer (OHE), Jon Sussex (RAND Europe), Dyfrig Hughes (Bangor University) and Nancy Devlin (OHE) has recently been published in BMC Health Services Research.

OHE publishes new Consulting Report on shaping the research agenda to estimate relevant cost-effectiveness thresholds for Health Technology Assessment decision making.

Just published is a book on the economics of end of life care, featuring a chapter by OHE’s Koonal Shah.

Dr Amanda Adler, Chair of NICE Appraisal Committee B and Consultant Physician, will present an OHE Seminar on 19 April 2016.

OHE’s Sarah Karlsberg Schaffer presented at the Glasgow Health Economics Seminar Series the results of a paper on the value of the cost-effectiveness threshold in Scotland.

Professor Weinstein compares the use of cost-per-QALY approaches in the UK and the US. Britain has got it closer to right, but may go a little too far.

OHE’s Deputy Director Paula Lorgelly will present an OHE Seminar on 14th December 2015 on the topic of HTA decision makers as budget takers and budget makers.

Recently published in Health Policy is an article by Sarah Karlsberg Schaffer, Jon Sussex, Nancy Devlin and Andrew Walker entitled “Local health care expenditure plans and their opportunity costs”.

This post summarises OHE’s activities at this year HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad and a new drug development paradigm.

Pages

Subscribe to RSS - NICE